Lista de obras -

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

scientific article published on 18 December 2019

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

scholarly article by Mara ten Kate et al published July 2016 in Alzheimer's and Dementia

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

scholarly article by Mara ten Kate et al published July 2016 in Alzheimer's and Dementia

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

artículo científico publicado en 2017

Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

scholarly article by Lyduine Collij et al published 12 October 2018 in The Journal of Nuclear Medicine

Association of amyloid pathology with memory performance and cognitive complaints in cognitively normal older adults: a monozygotic twin study

artículo científico publicado en 2019

Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline

artículo científico publicado en 2018

CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

article by Mara ten Kate et al published July 2017 in Alzheimer's and Dementia

Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

artículo científico publicado en 2017

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

artículo científico publicado en 2020

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

artículo científico publicado en 2019

Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change

scholarly article by Lianne M. Reus et al published September 2018 in Journal of Psychiatric Research

Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers

artículo científico publicado en 2016

Functional brain network centrality is related to APOE genotype in cognitively normal elderly

artículo científico publicado en 2018

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH TIME TO CLINICAL PROGRESSION IN MILD COGNITIVE IMPAIRMENT, INDEPENDENT OF AMYLOID STATUS

article by Betty M Tijms et al published July 2016 in Alzheimer's and Dementia

Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

artículo científico publicado en 2020

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults.

artículo científico publicado en 2018

Gray matter network disruptions and amyloid beta in cognitively normal adults

artículo científico publicado en 2015

Gray matter network measures are associated with cognitive decline in mild cognitive impairment

artículo científico publicado en 2017

Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease

artículo científico publicado en 2017

Grey matter network disruptions are related to amyloid beta in cognitively healthy elderly

article by Betty M Tijms et al published July 2015 in Alzheimer's and Dementia

Grey matter network disruptions are related to amyloid-beta in cognitively healthy elderly

article by Betty M Tijms et al published July 2015 in Alzheimer's and Dementia

Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

artículo científico publicado en 2015

Impact of ApoE-Ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

article by Mara ten Kate et al published July 2015 in Alzheimer's and Dementia

Impact of ApoE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

article by Mara ten Kate et al published July 2015 in Alzheimer's and Dementia

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

scholarly article by Mara Ten Kate et al published 27 September 2018 in Alzheimers Research & Therapy

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

scientific article published on 08 May 2019

Retinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions

artículo científico publicado en 2018

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

artículo científico publicado en 2019

Secondary prevention of Alzheimer's dementia: neuroimaging contributions

artículo científico publicado en 2018

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

artículo científico publicado en 2017

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.

artículo científico publicado en 2018

The EMIF-AD PreclinAD study: study design and baseline cohort overview

article by Elles Konijnenberg et al published 4 August 2018 in Alzheimers Research & Therapy

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

scientific article published on 01 January 2020

What determines cognitive functioning in the oldest-old? The EMIF-AD 90+ Study

artículo científico publicado en 2020

White matter hyperintensities and vascular risk factors in monozygotic twins.

artículo científico publicado en 2018

White matter microstructure disruption in early stage amyloid pathology

artículo científico publicado en 2021

Lista de obras de

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

Association of amyloid pathology with memory performance and cognitive complaints in cognitively normal older adults: a monozygotic twin study

Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline

CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change

Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers

Functional brain network centrality is related to APOE genotype in cognitively normal elderly

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH TIME TO CLINICAL PROGRESSION IN MILD COGNITIVE IMPAIRMENT, INDEPENDENT OF AMYLOID STATUS

Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults.

Gray matter network disruptions and amyloid beta in cognitively normal adults

Gray matter network measures are associated with cognitive decline in mild cognitive impairment

Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease

Grey matter network disruptions are related to amyloid beta in cognitively healthy elderly

Grey matter network disruptions are related to amyloid-beta in cognitively healthy elderly

Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

Impact of ApoE-Ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

Impact of ApoE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

Retinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

Secondary prevention of Alzheimer's dementia: neuroimaging contributions

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.

The EMIF-AD PreclinAD study: study design and baseline cohort overview

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

What determines cognitive functioning in the oldest-old? The EMIF-AD 90+ Study

White matter hyperintensities and vascular risk factors in monozygotic twins.

White matter microstructure disruption in early stage amyloid pathology